Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
05/16/2002 | US20020058029 Anti-CD40L, anti-B7.1 (CD80), anti-B7.2(CD86), CD40 antibody or anti-CD4 antibody; both may be administered separately or in combination, and in any order. |
05/16/2002 | US20020056206 Spray drying process and compositions of fenofibrate |
05/16/2002 | CA2428669A1 High-density lipoprotein-cholesterol level elevating agent |
05/16/2002 | CA2428492A1 Method for screening agents by modulating the expression of sparc |
05/16/2002 | CA2428204A1 Lipid peroxide-lowering compositions |
05/16/2002 | CA2428176A1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
05/16/2002 | CA2428159A1 Delayed-release pharmaceutical formulations containing proinsulin c-peptide |
05/16/2002 | CA2427757A1 Therapeutic uses for ip3 receptor-mediated calcium channel modulators |
05/16/2002 | CA2427350A1 Pyrimidine derivatives and their use as neuropeptide y receptor ligands |
05/16/2002 | CA2426730A1 Calcilytic compounds |
05/16/2002 | CA2426037A1 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
05/16/2002 | CA2421594A1 3-substituted oxindole beta 3 agonists |
05/16/2002 | CA2421154A1 Peroxisome proliferator activated receptor alpha agonists |
05/15/2002 | EP1205489A1 Polypeptide and nucleic acids encoding the same |
05/15/2002 | EP1205478A1 p38MAP KINASE INHIBITORS |
05/15/2002 | EP1205477A1 Mutual prodrug of amlodipine and atorvastatin |
05/15/2002 | EP1205191A1 Targeted modification of intracellular compounds |
05/15/2002 | EP1204748A2 New g-protein coupled receptor and dna sequences thereof |
05/15/2002 | EP1204674A2 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders |
05/15/2002 | EP1204665A2 Chemokine receptor antagonists and methods of use therefor |
05/15/2002 | EP1204660A1 Serotonergic benzothiophenes |
05/15/2002 | EP1204659A2 Serotonergic benzofurans |
05/15/2002 | EP1204658A1 Benzofurylpiperazine serotonin agonists |
05/15/2002 | EP1204656A2 A crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl) ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene hydrochloride |
05/15/2002 | EP1204655A2 A crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
05/15/2002 | EP1204654A1 Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists |
05/15/2002 | EP1204652A1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
05/15/2002 | EP1204646A1 1,4,5,6 -tetrahydropyrimidine derivative as a vitronectin inhibitor |
05/15/2002 | EP1204626A1 Ether compounds, compositions, and uses thereof |
05/15/2002 | EP1204429A2 Sustained release formulation of a peptide |
05/15/2002 | EP1204414A2 Use of morphinan derivates as medicines |
05/15/2002 | EP1167360A9 Human chymase inhibitors |
05/15/2002 | EP1082028B1 Matthiola seed oil, mixtures containing it and use thereof |
05/15/2002 | EP1049694B1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines |
05/15/2002 | EP0751775B1 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide derivatives |
05/15/2002 | EP0750509B1 USE OF IL-12 AND IL-12 ANTAGONISTS for the manufacture of a pharmaceutical composition for THE TREATMENT OF AUTOIMMUNE DISEASES |
05/15/2002 | EP0748314B1 Tetrasubstituted imidazole derivatives, method for preparing the same, use thereof as drugs, and pharmaceutical compositions containing the same |
05/15/2002 | CN1349527A Substituted benzolactam compounds |
05/15/2002 | CN1349525A Di-aryl acid derivatives as PPAR receptor ligands |
05/15/2002 | CN1349519A Glucokinase activators |
05/15/2002 | CN1349510A Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
05/15/2002 | CN1349509A Heterocyclic urea and related compounds useful as anti-inflammatory agents |
05/15/2002 | CN1349502A Method for the prepn. of tricyclic amino alcohol derivatives through azides |
05/15/2002 | CN1349496A Caspase inhibitors and the use thereof |
05/15/2002 | CN1349485A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
05/15/2002 | CN1349404A Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis treatment of obesity |
05/15/2002 | CN1348815A Medicine for preventing and treating coronary heart disease and angina pectoris and its prepn and other use |
05/15/2002 | CN1348786A Antilipemic slimming tea prepn |
05/15/2002 | CN1348785A Medicine 'Xuewang' for treating anemia |
05/15/2002 | CN1348778A Chinese medicine prepn for treating AIDS, cancer, hepatitis, diabetes and angiopathy |
05/15/2002 | CN1348768A 活性山羊血粉胶囊 Activity goat blood meal capsule |
05/15/2002 | CN1348763A Medicine composite for preventing or treaitng diseases relating to IL-12 over growth |
05/15/2002 | CN1348762A Application of kusheng (sophora Flavescences) flavone in preparing hypoglycemic |
05/15/2002 | CN1348717A Diatotherapeutic flour for treating diabetes and its production process |
05/15/2002 | CN1084747C Azolobenzazepine derivs, as neurological active agents |
05/15/2002 | CN1084744C N-substituted azaheterocyclic compounds |
05/15/2002 | CN1084741C Novel benzothiepines having activities as inhibitors of ileal bile acid transport and taurocholate uptake |
05/15/2002 | CN1084736C Substituted bheterocyclic carboxamide esters, their prepn. and their use as pharmaceuticals |
05/14/2002 | US6388088 Antidiabetic agents |
05/14/2002 | US6388071 Alkynyl phenyl heteroaromatic glucokinase activators |
05/14/2002 | US6388053 Mixing glucagon-like peptide-1 with a divalent metal cation, then incubating to form a complex; antidiabetic agents |
05/14/2002 | US6388047 Hydrophobic, hydrophilic macromolecules |
05/14/2002 | US6387944 Benzo(b)thiepine-1,1-dioxide derivatives, a method for the production thereof, medicaments containing these compounds, and their use |
05/14/2002 | US6387941 Antiserotonine agents |
05/14/2002 | US6387937 Indole derivatives |
05/14/2002 | US6387935 Polycyclic dihydrothiazoles having substituted alkyl radicals in the two-position, process for their preparation, and their use as pharmaceuticals |
05/14/2002 | US6387934 2-Cyano-3,5-dihydroxyhex-2-enecarboxamide derivatives |
05/14/2002 | US6387932 Somatostatin agonists |
05/14/2002 | US6387929 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
05/14/2002 | US6387919 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
05/14/2002 | US6387899 Antiserotonine agents; antidepressants |
05/14/2002 | US6387894 Use of CRF antagonists and renin-angiotensin system inhibitors |
05/14/2002 | US6387892 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
05/14/2002 | US6387883 Method for the prevention and treatment of cachexia and anorexia |
05/14/2002 | US6387663 Fusion protein of collagen binding domain and angiogenesis modulating domain; treatment of cardiovascular disorders; antiischemic agents |
05/14/2002 | CA2255665C Creatine pyruvates and method for their production |
05/14/2002 | CA2251991C Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents |
05/14/2002 | CA2089742C Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus |
05/10/2002 | WO2002036771A2 Imaging, diagnosis and treatment of disease |
05/10/2002 | WO2002036765A1 Novel protein and dna thereof |
05/10/2002 | WO2002036741A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
05/10/2002 | WO2002036602A1 Novel pyrazole derivatives and diabetes remedies containing the same |
05/10/2002 | WO2002036597A1 Tricyclic derivatives of indole with antiangiogenic activity |
05/10/2002 | WO2002036584A1 Cholesterol lowering benzo`b! thiophenes and benzo`d! isothiazoles |
05/10/2002 | WO2002036573A2 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents |
05/10/2002 | WO2002036563A1 Crystalline forms of fluvastatin sodium |
05/10/2002 | WO2002036543A1 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride and glycine chloride |
05/10/2002 | WO2002036151A2 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
05/10/2002 | WO2002036134A1 Pharmaceutical or dietary composition containing a vegetable oil, in particular olive oil, and sitosterol |
05/10/2002 | WO2002036116A2 Tripeptidyl peptidase inhibitors |
05/10/2002 | WO2002036115A1 Sulphonamides for the treatment of central nervous system diseases |
05/10/2002 | WO2002036111A1 New use of 2-(4-isobutylphenyl)propionic acid |
05/10/2002 | WO2002036109A2 Use of pyridoxamine for the treatment and inhibition of obesity-related complications |
05/10/2002 | WO2002036100A1 Controlled release metformin compositions |
05/10/2002 | WO2002036093A2 Anti-adiposis composition based on garlic bulb extracts |
05/10/2002 | WO2002036073A2 Receptor antagonist-lipid conjugates and delivery vehicles containing same |
05/10/2002 | WO2002035942A1 Food grade transglutaminase inhibitor and uses thereof |
05/10/2002 | WO2002015927A8 High mannose proteins and methods of making high mannose proteins |
05/10/2002 | WO2002012238A3 2-(4-PYRIDYL)AMINO-6-DIALKOXYPHENYL-PYRIDO[2,3-d]PYRIMIDIN-7-ONES |
05/10/2002 | WO2002008200A3 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists |